Skip to main content
. Author manuscript; available in PMC: 2018 Mar 27.
Published in final edited form as: AIDS. 2017 Mar 27;31(6):797–806. doi: 10.1097/QAD.0000000000001427

Table 3.

Correlation Analysis for Percent Change at Week 52 and Baseline Demographics (mITT population)

Percent Change sCD14 Percent Change oxLDL Percent Change Lp-PLA2
Age ρ= −0.07
P= 0.36
ρ= −0.07
P=0.32
ρ= −0.11
P=0.12
Framingham Risk Score ρ= −0.09
P=0.23
ρ= 0.05
P=0.48
ρ= −0.04
P=0.60
CD4 count ρ= 0.09
P=0.22
ρ= −0.01
P=0.87
ρ=0.02
P=0.74
Log HIV-1 Viral Load ρ= 0.04
P=0.54
ρ= 0.06
P=0.43
ρ=0.14
P=0.06
LDL-C ρ= −0.01
P=0.87
ρ= −0.17
P=0.02
ρ= −0.27
P=0.0002
sCD14 ρ= −0.48
P < 0.0001
ρ= −0.08
P=0.25
ρ= −0.03
P=0.67
oxLDL ρ= −0.02
P=0.75
ρ= −0.33
P < 0.0001
ρ= −0.03
P=0.66
Lp-PLA2 ρ= −0.04
P=0.56
ρ= 0.03
P=0.65
ρ= −0.27
P=0.0002

Significant P-values are shown in bold. Data are shown for mITT population with biomarker specimens available for Week 52.

Abbreviations: LDL-C, low density lipoprotein cholesterol; sCD14, soluble CD14; oxLDL, oxidized low density lipoprotein, Lp-PLA2, lipoprotein-associated phospholipase A